一个心脏毒性数据集用于乳腺癌患者
Beatriz Piñeiro-Lamas1, Ana López-Cheda2, Ricardo Cao2
1Grupo MODES, Departamento de Matemáticas, CITIC, Universidade da Coruña, A Coruña, 15071, Spain. b.pineiro.lamas@udc.es.
Scientific data
|August 8, 2023
概括
这一数据集探讨了接受心脏毒性治疗的HER2+乳腺癌妇女心脏功能障碍的预测因素. 早期发现心血管不良事件对于改善预后至关重要.
科学领域:
- 心脏病学 心脏病学
- 在瘤学瘤学.
- 医学数据科学 医学数据科学
背景情况:
- HER2+ 乳腺癌治疗可以引起心脏毒性.
- 心血管不良事件,如心脏缩功能障碍,具有临床和预后影响.
- 需要及早检测心脏问题.
研究的目的:
- 为研究HER2+乳腺癌患者心脏毒性预测因子提供数据集.
- 促进研究瘤疗法的心血管副作用.
主要方法:
- 数据集由科鲁尼亚大学和科鲁尼亚大学医院的合作编制.
- 包括531名患有HER2+乳腺癌的女性的数据.
- 可提供心声谱测量,包括心肌速度和临床变量.
主要成果:
- 数据集包含患者的人口统计数据 (年龄,体重,身高).
- 心声图数据包括治疗前和治疗期间的心脏功能测量.
- 对于受影响的患者,记录了与癌症治疗相关的心脏功能障碍发生的时间.
结论:
- 这一数据集使得早期发现心脏功能障碍的研究成为可能.
- 促进对乳腺癌患者心血管副作用的理解.
- 旨在推进有关心脏毒性预测和管理的研究.
相关概念视频
Blood Studies for Cardiovascular System I: Cardiac Biomarkers
201
Cardiac biomarkers are enzymes, proteins, and hormones released into the blood when cardiac cells are injured. They are powerful tools for triaging.
The essential diagnostic tools for detecting myocardial necrosis and monitoring individuals suspected of having acute coronary syndrome (ACS) include:
Troponins
Troponins, particularly cardiac troponins I and T, are the most precise and sensitive markers of myocardial injury. They are detectable within 4-6 hours of myocardial injury and remain...
The essential diagnostic tools for detecting myocardial necrosis and monitoring individuals suspected of having acute coronary syndrome (ACS) include:
Troponins
Troponins, particularly cardiac troponins I and T, are the most precise and sensitive markers of myocardial injury. They are detectable within 4-6 hours of myocardial injury and remain...
201
Cardiovascular Drugs: Classification based on Therapeutic Indications
2.9K
Cardiovascular diseases, encompassing a range of conditions, can significantly affect the heart's operations and the overall circulatory system. These conditions impair the heart's ability to pump blood, leading to a deficit in oxygen supply to crucial organs. Anomalies in the heart's electrical system, known as arrhythmias, can cause heartbeats to accelerate or slow down. Usually, heart rates increase during physical activity and decrease while resting or sleeping. However,...
2.9K
Cardiomyopathy V: Interprofessional Care
16
Managing cardiomyopathy involves addressing underlying or precipitating causes, treating heart failure with medications, and implementing dietary changes and a balanced exercise and rest regimen.Lifestyle ModificationsCardiomyopathy patients should adopt a low-sodium diet to reduce fluid retention and manage heart failure. A personalized exercise and rest plan helps maintain physical fitness without overstraining the heart. Avoiding alcohol and tobacco is essential to prevent further damage to...
16
Cardiomyopathy II: Dilated Cardiomyopathy
11
Dilated cardiomyopathy, or DCM, is a progressive myocardial disorder characterized by ventricular chamber dilation and contractile dysfunction.EtiologyVarious factors can cause DCM, including hypertension and heavy alcohol intake, which contribute to the weakening and enlargement of the heart muscle. Viral infections, such as Coxsackievirus B, adenoviruses, and influenza, can lead to DCM by causing inflammation and damage to heart tissue. Certain chemotherapeutic agents, including daunorubicin,...
11
Cardiomyopathy VI: Nursing Management
13
Assessment: Nursing management of patients with cardiomyopathy begins with a thorough assessment of the patient's history, including a family history of cardiomyopathy or sudden cardiac death, personal history of heart disease, hypertension, diabetes, and any alcohol consumption or drug use.During the physical examination, assess vital signs, look for signs of heart failure (such as edema, jugular venous distention, and cyanosis), auscultate for abnormal heart sounds (like murmurs and gallops),...
13
Heart Failure Drugs: β-Blockers
364
β-adrenergic antagonists, commonly known as β-blockers, block the effects of sympathetic neurotransmitters such as noradrenaline (NA) and adrenaline (ADR). They have several beneficial effects in heart failure treatment. They reduce heart rate, the force of contraction, and cardiac muscle relaxation. They also slow the atrial-ventricular conduction rate and raise the threshold for arrhythmias. The concentration of β-blockers determines their effects on bronchodilation,...
364


